ACL - Alcon Inc. patents

This listing is of recent patents (patent applications) which may be related to Alcon Inc. according to a patent app search. In *most* cases, they are listed under Alcon Inc. because the company is listed in the Agent field of the patent application. Note: Alcon Inc. (ACL) may have other listings under a different name, spelling or agent. If there is another company with a similar name, it's possible their patents could be inadvertantly included here. Notify us of any issues. Also, FreshPatents.com is not affiliated with Alcon Inc., we're just tracking patents related to them as published publically by the USPTO. Full list of Stock Symbols and Company RSS Feeds

SUBSCRIBE to updates on this page: Alcon Inc. patents RSS Feed (FREE)

A

A
AA
AAPL
AATI
ABIO
ABT
ACL
A
ADBE
ADM
AEIS
AEP
AERO
AFFX
AGN
AGX
AIRT
AKAM
ALB
ALGN
ALTR
ALU
ALV
AMAT
AMD
AMGN
AMLN
ANGO
AOL
ARAY
ARB
ARIA
ARNA
ARRS
ARRY
ASH
ATHR
ATI
AVGO
AVID
AVP
AWI
AXA
AXP
AXTI

Symbol	Company	Application #	Date	Title
ACL	Alcon	20120116216	20120510	Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
ACL	Alcon	20120115870	20120510	Control of intraocular pressure using alk5 modulation agents
ACL	Alcon	20120115829	20120510	Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
ACL	Alcon	20120108632	20120503	Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
ACL	Alcon	20120108557	20120503	Fluoroquinolone derivatives for ophthalmic applications
ACL	Alcon	20120101160	20120426	Use of chemical chaperones to treat glaucoma caused by misfolded or misprocessed proteins
ACL	Alcon	20120100153	20120426	Stable and soluble antibodies
ACL	Alcon	20120074624	20120329	Furnace furniture
ACL	Alcon	20120077698	20120329	High throughput assay for cancer cell growth inhibition
ACL	Alcon	20120077864	20120329	Rnai-mediated inhibition of gremlin for treatment of iop-related conditions
ACL	Alcon	20120078242	20120329	Attenuated rf power for automated capsulorhexis
ACL	Alcon	20120070402	20120322	Polymeric artificial tear system
ACL	Alcon	20120065578	20120315	Phacoemulsification hand piece with two independent transducers
ACL	Alcon	20120064077	20120315	Stable and soluble antibodies inhibiting tnf alpha
ACL	Alcon	20120060808	20120315	Crossbow trigger assembly
ACL	Alcon	20120046285	20120223	Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
ACL	Alcon	20120038222	20120216	Self-matching pulse generator with adjustable pulse width and pulse frequency
ACL	Alcon	20120023649	20120202	Dry trap valve for use in a non-flushing urinal and other drains
ACL	Alcon	20120014958	20120119	Stable and soluble antibodies inhibiting vegf
ACL	Alcon	20120004528	20120105	Implantable remote monitoring sensor
ACL	Alcon	20120004245	20120105	Compounds for the treatment of posterior segment disorders and diseases
ACL	Alcon	20110319810	20111229	Curved infusion sleeve
ACL	Alcon	20110313343	20111222	Phacoemulsification fluidics system having a single pump head
ACL	Alcon	20110301425	20111208	Inductive task light for surgical console
ACL	Alcon	20110300019	20111208	Use of pbo-peo-pbo block copolymers in ophthalmic compositions
ACL	Alcon	20110295191	20111201	Infusion pressure monitoring system
ACL	Alcon	20110288101	20111124	Surgical compositions containing sigma-receptor agonists
ACL	Alcon	20110288157	20111124	Rnai-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
ACL	Alcon	20110275593	20111110	Stabilized ophthalmic galactomannan formulations
ACL	Alcon	20110274322	20111110	Devices and methods for assessing changes in corneal health
ACL	Alcon	20110269822	20111103	Rnai-mediated inhibition of histamine receptor h1-related conditions
ACL	Alcon	20110268728	20111103	Solubility optimization of immunobinders
ACL	Alcon	20110258953	20111027	Slab edge casing and method therefor
ACL	Alcon	20110256156	20111020	Transferrin/transferrin receptor-mediated sirna delivery
ACL	Alcon	20110257246	20111020	Rnai-mediated inhibition of hif1a for treatment of ocular angiogenesis
ACL	Alcon	20110257248	20111020	Rnai-related inhibition of tnfa signaling pathway for treatment of ocular angiogenesis
ACL	Alcon	20110257658	20111020	Modular intraocular lens injector device
ACL	Alcon	20110248671	20111013	Power system implantable in eye
ACL	Alcon	20110245319	20111006	Rnai-mediated inhibition of rho kinase for treatment of ocular disorders
ACL	Alcon	20110230877	20110922	Pulsed electric field probe for glaucoma surgery
ACL	Alcon	20110230410	20110922	Low density lipoprotein receptor-mediated sirna delivery
ACL	Alcon	20110214359	20110908	Circular motion theater
ACL	Alcon	20110207809	20110825	Method of accelerating corneal wound healing
ACL	Alcon	20110200594	20110818	Functionalized polypeptides
ACL	Alcon	20110202049	20110818	Small gauge ablation probe for glaucoma surgery
ACL	Alcon	20110195962	20110811	Use of multi-pharmacophore compounds to treat nasal disorders
ACL	Alcon	20110195132	20110811	Self-preserved aqueous pharmaceutical compositions
ACL	Alcon	20110190381	20110804	Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
ACL	Alcon	20110190376	20110804	Rnai-related inhibition of tnfa signaling pathway for treatment of macular edema
ACL	Alcon	20110190203	20110804	Ophthalmic compositions containing a synergistic combination of two polymers
ACL	Alcon	20110180565	20110728	Method and apparatus for dispensing product
ACL	Alcon	20110178202	20110721	Visible light absorbers for ophthalmic lens materials
ACL	Alcon	20110164218	20110707	Method and apparatus for ocular surface imaging
ACL	Alcon	20110160308	20110630	Use of monoamine oxidase inhibitors to treat outer retina disorders
ACL	Alcon	20110160210	20110630	Control of intraocular pressure using alk5 modulation agents
ACL	Alcon	20110160172	20110630	Fluoroquinolone derivatives for ophthalmic applications
ACL	Alcon	20110159007	20110630	Stable and soluble antibodies inhibiting tnf alpha
ACL	Alcon	20110151017	20110623	Ophthalmic solutions with improved disinfection profiles
ACL	Alcon	20110152505	20110623	Method for decreasing immunogenicity
ACL	Alcon	20110142767	20110616	Rnai-mediated inhibition of tumor necrosis factor alpha-related conditions
ACL	Alcon	20110144127	20110616	Agents for treatment of glaucomatous retinopathy and optic neuropathy
ACL	Alcon	20110144562	20110616	Localized pharmacological treatment of ocular tissue using high-intensity pulsed electrical fields
ACL	Alcon	20110144567	20110616	Phacoemulsification hand piece with integrated aspiration pump and cartridge
ACL	Alcon	20110144638	20110616	Localized shockwave-induced tissue disruption
ACL	Alcon	20110144641	20110616	High-intensity pulsed electric field vitrectomy apparatus
ACL	Alcon	20110135579	20110609	Rnai-related inhibition of tnfa signaling pathway for treatment of glaucoma
ACL	Alcon	20110135626	20110609	Localized chemical lysis of ocular tissue
ACL	Alcon	20110135644	20110609	Methods and compositions for enhanced delivery of macromolecules
ACL	Alcon	20110135743	20110609	Carboxyvinyl polymer-containing nanoparticle suspensions
ACL	Alcon	20110137231	20110609	Phacoemulsification hand piece with integrated aspiration pump
ACL	Alcon	20110137232	20110609	Thermal management algorithm for phacoemulsification system
ACL	Alcon	20110130451	20110602	Method of treating dry eye disorders and uveitis
ACL	Alcon	20110124734	20110526	N-halogenated amino acid formulations and methods for cleaning and disinfection
ACL	Alcon	20110124708	20110526	Rnai-mediated inhibition of ocular hypertension targets
ACL	Alcon	20110117091	20110519	Humanization of rabbit antibodies using a universal antibody framework
ACL	Alcon	20110118729	20110519	High-intensity pulsed electric field vitrectomy apparatus with load detection
ACL	Alcon	20110118728	20110519	Control of high-intensity pulsed electrical fields in surgical applications
ACL	Alcon	20110118734	20110519	Capsularhexis device using pulsed electric fields
ACL	Alcon	20110113113	20110512	Social network system and method of operation
ACL	Alcon	20110112976	20110512	Social network system and method of operation
ACL	Alcon	20110112038	20110512	Novel npr-b agonists
ACL	Alcon	20110111055	20110512	Nutritional supplements for relief of dry eye
ACL	Alcon	20110110456	20110512	Common wave and sideband mitigation communication systems and methods for increasing communication speeds, spectral efficiency and enabling other benefits
ACL	Alcon	20110105453	20110505	Superoxide dismutase mimics for the treatment of optic nerve and retinal damage
ACL	Alcon	20110105574	20110505	Pai-1 expression and activity inhibitors for the treatment of ocular disorders
ACL	Alcon	20110105765	20110505	Uv-absorbers for ophthalmic lens materials
ACL	Alcon	20110106096	20110505	Monitoring thermal conditions to vary operation of an ultrasonic needle tip of a surgical instrument
ACL	Alcon	20110098314	20110428	Statins for the treatment of ocular hypertension and glaucoma
ACL	Alcon	20110092523	20110421	Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
ACL	Alcon	20110088504	20110421	Grip shifter assembly
ACL	Alcon	20110082092	20110407	Interfering rna delivery system and uses thereof
ACL	Alcon	20110082125	20110407	Topical ophthalmic or otic solution formulations containing moxifloxacin hydrocholoride and dexamethasone phosphate
ACL	Alcon	20110082145	20110407	Olopatadine compositions and uses thereof
ACL	Alcon	20110082200	20110407	5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses
ACL	Alcon	20110077381	20110331	Novel npr-b agonists
ACL	Alcon	20110071459	20110324	Power saving glaucoma drainage device
ACL	Alcon	20110071458	20110324	Glaucoma drainage device with pump
ACL	Alcon	20110071454	20110324	Power generator for glaucoma drainage device
ACL	Alcon	20110071116	20110324	Antimicrobial n-halogenated amino acid salts
ACL	Alcon	20110060044	20110310	Aliphatic acid-containing n-halogenated amino acid formulations
ACL	Alcon	20110059039	20110310	Use of peo-pbo block copolymers in ophthalmic compositions
ACL	Alcon	20110054008	20110303	Rnai inhibition of serum amyloid a for treatment of glaucoma
ACL	Alcon	20110043760	20110224	Fixed optical system having an adjustable target
ACL	Alcon	20110042597	20110224	Magnetically driven high speed pneumatic valve
ACL	Alcon	20110046258	20110224	Ophthalmic and otorhinolaryngological device materials
ACL	Alcon	20110046259	20110224	Uv-absorbers for ophthalmic lens materials
ACL	Alcon	20110038174	20110217	Ophthalmic endoillumination with light collector for white phosphor
ACL	Alcon	20110037949	20110217	Ophthalmic endoillumination with thermally isolated phosphor
ACL	Alcon	20110037948	20110217	White light emitting diode (led) illuminator for ophthalmic endoillumination
ACL	Alcon	20110034864	20110210	Phacoemulsification handpiece pressure booster
ACL	Alcon	20110028534	20110203	Rnai inhibition of ctgf for treatment of ocular disorders
ACL	Alcon	20110022170	20110127	Truncated diffractive intraocular lenses
ACL	Alcon	20110022117	20110127	Cytokine production via electrical stimulation to treat glaucoma
ACL	Alcon	20110020912	20110127	Method for the construction of randomized gene sequence libraries in cells
ACL	Alcon	20110022118	20110127	Application of an electrical field in the vicinity of the trabecular meshwork to treat glaucoma
ACL	Alcon	20110015563	20110120	Method of controlling a surgical system based on a rate of change of an operating parameter
ACL	Alcon	20110015271	20110120	Topical nepafenac formulations
ACL	Alcon	20110015151	20110120	Combination of viscoelastics for use during surgery
ACL	Alcon	20110011392	20110120	Olopatadine nasal spray regimen for children
ACL	Alcon	20110008276	20110113	Ethyleneoxide butyleneoxide block copolymer compositions
ACL	Alcon	20110009322	20110113	Use of bradykinin and related b2r agonists to treat ocular hypertension and glaucoma

###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Alcon Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Alcon Inc. with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###